Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine
Authors
Keywords
UGT1A4, Polymorphisms, Lamotrigine, Glucuronidation, Serum concentration
Journal
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
Volume 41, Issue 2, Pages 149-155
Publisher
Springer Nature
Online
2014-12-09
DOI
10.1007/s13318-014-0247-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains
- (2013) Chaitali Ghosh et al. EPILEPSIA
- The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
- (2013) Andrew Rowland et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations
- (2013) Marisol López et al. MOLECULAR BIOLOGY REPORTS
- UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems
- (2012) T Haslemo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Enzyme induction with antiepileptic drugs: Cause for concern?
- (2012) Martin J. Brodie et al. EPILEPSIA
- Adherence to antiepilepsy drug therapy
- (2012) Edward Faught EPILEPSY & BEHAVIOR
- Glucuronidation of the second-generation antipsychotic clozapine and its active metabolite N-desmethylclozapine. Potential importance of the UGT1A1 A(TA)7TAA and UGT1A4 L48V polymorphisms
- (2012) Kathryn K. Erickson-Ridout et al. Pharmacogenetics and Genomics
- The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy
- (2011) Medine Idrizoglu Gulcebi et al. EPILEPSY RESEARCH
- Lamotrigine and its N2-glucuronide during pregnancy: The significance of renal clearance and estradiol
- (2011) Arne Reimers et al. EPILEPSY RESEARCH
- Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants
- (2011) Kathryn Kelly Erickson-Ridout et al. Pharmacogenetics and Genomics
- Functional analysis of UGT1A4P24Tand UGT1A4L48Vvariant enzymes
- (2011) Jin Zhou et al. PHARMACOGENOMICS
- Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients
- (2010) Roza Ghotbi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Analysis of inherited genetic variations at theUGT1locus in the French-Canadian population
- (2009) Vincent Ménard et al. HUMAN MUTATION
- A pharmacogenetics study of the human glucuronosyltransferase UGT1A4
- (2009) Marie-Odile Benoit-Biancamano et al. Pharmacogenetics and Genomics
- Variation in glucuronidation of lamotrigine in human liver microsomes
- (2009) U. A. Argikar et al. XENOBIOTICA
- Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines
- (2008) A. Nakamura et al. DRUG METABOLISM AND DISPOSITION
- Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy
- (2008) Inger Öhman et al. EPILEPSIA
- Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population
- (2007) Keith L. Davis et al. EPILEPSIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now